# METADX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/metadx

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.metadxlab.com
- Total disclosed funding: $0.3M
- Latest round: Seed (Apr 3, 2025)
- Investors on record: 4

## About

Based in Seoul, South Korea, founded in 2024, METADX Co., Ltd. operates as a pet healthcare solutions company that creates AI solutions for veterinary medicine. In October 2024, METADX raised seed funding led by investor Korea Investment Accelerator. The firm as of December 2024, is led by its co-founder and CEO, Chris Kim,  Vice President, Inyoung Choi, and co-founder and CTO, Giup Jang.

MetaDx’s primary offerings include CancerVET™, an AI-based platform designed to detect tumors in pets by analyzing biomarkers in their serum, and VitalVET™, an AI-driven anesthesia monitoring system that predicts anesthesia depth and emergency situations based on real-time vital signs. The company also provides TraceVET™, a referral testing service that streamlines diagnostic testing for veterinarians by handling tests in a central laboratory, ensuring quality results.

The company plans to utilize the October 2024 funding to grow its R&D infrastructure and prepare for global expansion.

## Funding rounds

- Seed, Apr 3, 2025, $0.3M — KAIST Ventures
- Seed, Oct 21, 2024 — Korea Investment Partners
- Seed, Jul 26, 2024 — Korea Tech Incubator for Startup, The Yoonmin Foundation

## Investors

- Korea Tech Incubator for Startup — Seed
- The Yoonmin Foundation (https://capitalatlas.ai/funds/the-yoonmin-foundation) — Seed
- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Seed
- KAIST Ventures (https://capitalatlas.ai/funds/kaist-ventures) — Seed